Cyclophosphamide vs placebo
All‐cause mortality 12‐month · people with connective tissue disease‐associated interstitial lung disease
Cyclophosphamide showed no clear difference in all‐cause mortality 12‐month compared with placebo (low certainty).
1 finding from 1 review
- Cyclophosphamide for connective tissue disease–associated interstitial lung disease 2018 · Cochrane Headline outcomes onlyOR 0.94 [0.19, 4.77]2 studies · 179 participantsLow